Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Della Zuana

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Arzneimittel-Forschung|August 26, 1998
General pharmacology of S 15261, a new concept for treatment of diabetesJ Duhault, S Berger, M Boulanger, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1984
[Biochemical changes in 24-month-old Wistar rats]F Roman, O Della Zuana, M Lonchampt, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 2, 2002
Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley ratsO Della-Zuana, F Presse, C Ortola, et al.
Diabetologia|October 1, 1994
S15261, a new compound for the treatment of the insulin resistance syndromeJ Duhault, F Lacour, M Boulanger, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 16, 2002
Appetite suppression based on selective inhibition of NPY receptorsS Chamorro, O Della-Zuana, J-L Fauchère, et al.
Arzneimittel-Forschung|February 24, 2001
Preparation and pharmacological profile of 2-trifluoromethyl-benzo(8,9)-1,3-diaza-spiro (4,6)-undeca-2,8-diene and its enantiomers as new anti-obesity agentsM F Boussard, J P Guette, M Wierzbicki, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 13, 2001
Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockadeO Della Zuana, M Sadlo, M Germain, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
SLC-1 receptor mediates effect of melanin-concentrating hormone on feeding behavior in rat: a structure-activity studyT Suply, O Della Zuana, V Audinot, et al.
Canadian Journal of Physiology and Pharmacology|March 29, 2000
Food intake regulation in rodents: Y5 or Y1 NPY receptors or both?J Duhault, M Boulanger, S Chamorro, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|February 6, 2004
A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptorO Della-Zuana, L Revereault, A Beck-Sickinger, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Arzneimittel-Forschung|August 26, 1998
General pharmacology of S 15261, a new concept for treatment of diabetesJ Duhault, S Berger, M Boulanger, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1984
[Biochemical changes in 24-month-old Wistar rats]F Roman, O Della Zuana, M Lonchampt, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 2, 2002
Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley ratsO Della-Zuana, F Presse, C Ortola, et al.
Diabetologia|October 1, 1994
S15261, a new compound for the treatment of the insulin resistance syndromeJ Duhault, F Lacour, M Boulanger, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 16, 2002
Appetite suppression based on selective inhibition of NPY receptorsS Chamorro, O Della-Zuana, J-L Fauchère, et al.
Arzneimittel-Forschung|February 24, 2001
Preparation and pharmacological profile of 2-trifluoromethyl-benzo(8,9)-1,3-diaza-spiro (4,6)-undeca-2,8-diene and its enantiomers as new anti-obesity agentsM F Boussard, J P Guette, M Wierzbicki, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 13, 2001
Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockadeO Della Zuana, M Sadlo, M Germain, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
SLC-1 receptor mediates effect of melanin-concentrating hormone on feeding behavior in rat: a structure-activity studyT Suply, O Della Zuana, V Audinot, et al.
Canadian Journal of Physiology and Pharmacology|March 29, 2000
Food intake regulation in rodents: Y5 or Y1 NPY receptors or both?J Duhault, M Boulanger, S Chamorro, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|February 6, 2004
A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptorO Della-Zuana, L Revereault, A Beck-Sickinger, et al.
Pageof 1